Is There a Place for Fear of Blushing in Social Anxiety Spectrum?
About this workSummary, languages, provenance, and download
What you will learnThe main threads to follow while reading
Trace the path from the clinical question through measures to results, separating observed data from the proposed diagnostic interpretation.
In a few words (short summary)The book’s argument, structure, and limits
This coauthored clinical study asks whether fear of blushing forms a distinct profile within social-anxiety disorders and symptoms.
Antoine Pelissolo, Albert Moukheiber, Corine Lobjoie, Jean Valla, and Simon Lambrey study fear of blushing within social anxiety. The article presents its question, groups, measures, and statistical comparisons, then discusses the symptom’s possible place in a clinical spectrum. This is a jointly authored research paper, not a text expressing Moukheiber’s voice alone. Its findings should be read with the reported protocol and limitations, without turning a clinical association into an individual diagnosis.
Four-page AI synthesisA complete reading to browse without leaving the page
1. A Social Fear Organized Around a Visible Sign
The article begins with a focused clinical and classificatory problem. Fear of blushing in front of other people can cause considerable distress and impairment, yet it was not recognized as a specific diagnosis in the psychiatric classifications then in use. Blushing is one possible symptom of social anxiety disorder, but some patients describe a much narrower fear. Their primary concern is not deficient social skill, appearance in general, or unusual behavior. It is the prospect of blushing, being seen to blush, and being judged because an involuntary physical sign appears to expose emotion, weakness, or shyness.
This distinction matters because social anxiety disorder is itself heterogeneous. DSM-IV formally recognized only a generalized subtype, leaving other presentations in a broad nongeneralized category. Earlier research had nevertheless examined more specific patterns, including fear of public speaking or performing under observation. Two accounts competed. One treated such patterns as qualitatively distinct subtypes. The other described a severity continuum in which the number of feared situations bears a dose-like relationship to the disorder’s intensity and consequences, without a firm boundary between specific and generalized forms.
Fear of blushing shifts the debate from the range of feared situations to the nature of the feared symptom. The article places it beside fears of trembling, sweating, smelling, or urinating in the presence of others. In each case, a bodily event becomes socially threatening because it seems to reveal something unwanted. Ordinary social avoidance may therefore be joined by active attempts to hide or prevent the sign itself. Some patients say that they would have no social fear if they did not blush, raising the possibility that blushing is not merely one manifestation of anxiety but the event around which the anxiety is built.
The authors consequently test whether patients whose only reported social threat is blushing differ from two comparison groups: patients who fear blushing alongside other social threats, and patients with social anxiety disorder who do not fear blushing. The hypothesis is deliberately comparative. A distinct age of onset, comorbidity pattern, personality profile, or relationship between symptoms and disability would support a special place for fear of blushing within the social-anxiety spectrum. The study does not decide in advance what that place should be. Its closing alternatives, a subtype of social anxiety disorder or a form of social anxiety secondary to excessive blushing, depend on the evidence assembled between those two possibilities.
2. Three Groups, Multiple Measures, and an Unusual Referral Path
The initial sample consisted of 450 consecutive adult outpatients seeking treatment for social anxiety disorder at a university anxiety clinic in Paris. A DSM-IV diagnosis had to be confirmed, and social anxiety had to be the patient’s primary complaint and disorder. After written consent, participants completed a sociodemographic history and a clinical assessment based on an adapted MINI interview. Refusal, psychotic disorders, delirium, dementia, and language difficulties were among the exclusions. Twenty-one people were excluded, leaving 429 patients. This was therefore a treatment-seeking clinical population, not a student sample identified solely by elevated questionnaire scores.
Recruitment had a crucial feature. A total of 168 patients had been referred directly by a surgery department after initially requesting sympathectomy for excessive facial blushing. Roughly half had approached the surgeon themselves, while half had been referred by a general practitioner. The remaining participants reached the anxiety clinic through more conventional psychiatric or primary-care routes. This collaboration provided access to people who often understood their problem as physical and sought a radical bodily intervention before mental-health care. It also introduced a potential selection effect that the statistical analysis had to address rather than ignore.
The final sample was divided into three groups. Ninety-seven patients feared blushing and at least one other social threat; 142 identified blushing as their sole social threat; and 190 had social anxiety disorder without fear of blushing. Fear of blushing was defined as marked and persistent fear in social or performance situations. Two experienced clinicians assigned patients by consensus, drawing on the MINI and detailed material from the social-phobia section of another diagnostic interview. The resulting distinction is a structured clinical classification, but it is not based on an objective physiological measurement of facial color or blood flow.
Assessment extended well beyond a single symptom score. Measures covered social-anxiety severity, fear of negative evaluation, assertiveness, anxiety and depression, disability, global functioning, self-esteem, recalled childhood behavioral inhibition, and temperament and character traits. A six-item Salpêtrière questionnaire assessed the frequency and intensity of blushing, worry about it, helplessness, and its effect on daily life. The authors compared continuous scores, lifetime diagnoses, and current medication patterns. They also examined how blushing-fear intensity correlated with disability, functioning, symptoms, and personality, separately within the two groups that feared blushing. Adjusted analyses tested whether referral source, general anxiety, depression, or overall social-anxiety severity accounted for the principal differences.
3. A Distinct Profile Without Trivial Distress
The main result is not a simple contrast between people who fear blushing and everyone else. Patients who feared blushing alongside other social threats broadly resembled patients with social anxiety disorder but no fear of blushing in symptom burden and impairment. The combined-fear group did score higher on several measures of social fear, phobic symptoms, and disability, but the sharper divide concerned patients for whom blushing was the only social threat. That group differed across many clinical and personality measures, even though its members still experienced high social anxiety and substantial disruption of global functioning.
On average, the blushing-only group reported a later onset of the disorder: about 15.9 years of age, compared with 12.5 in the group with blushing plus other threats and 11.1 in the group without blushing fear. They also had fewer anxiety and depressive comorbidities and were less likely to be taking antidepressants, either alone or with anxiolytics. Lifetime major depression or dysthymia was reported in 37.6 percent of the blushing-only group, compared with 63.5 percent of the combined group and 70.9 percent of the social-anxiety group without blushing fear. Differences also appeared, to varying degrees, for panic or agoraphobia, generalized anxiety, and obsessive-compulsive disorder.
Personality and social-cognitive measures strengthened the contrast. The blushing-only patients recalled less behavioral inhibition during childhood, showed lower harm avoidance, and expressed less fear of negative evaluation. They had higher self-esteem and appeared more inclined toward novelty seeking and self-directedness. Most of these differences remained after the authors adjusted for social-anxiety severity, general anxiety, and depression. The finding is therefore not readily reduced to a milder position on a single social-anxiety continuum. The group appears to combine a narrowly concentrated fear with fewer of the broader temperamental, cognitive, and comorbid features found in the other patients.
Lower morbidity on several dimensions did not make the blushing-only condition minor. This group had the highest score on the specific fear-of-blushing questionnaire and reported considerable discomfort and suffering. Within this group, the intensity of fear of blushing related to disability and global functioning in ways not seen when other social fears were also present. Blushing fear seems to determine perceived disability when it stands alone, whereas it adds comparatively little to overall morbidity in a broader social-anxiety presentation. The surgical referral route makes the paradox especially visible: patients may have fewer psychiatric comorbidities and little prior contact with mental-health services, yet feel distressed enough to request a major physical intervention.
4. Competing Interpretations, Firm Limits, and Clinical Implications
The discussion proposes two forms of fear of blushing. In one, blushing is a symptom among several social fears and does not substantially alter the profile of social anxiety disorder. In the other, it is the sole social threat and accompanies later onset, fewer comorbid disorders, less inhibition, and a strongly physical understanding of the problem. If replicated, this second pattern might justify a specifier or subtype within social anxiety disorder. Alternatively, it could be classified as a secondary form of social anxiety driven by excessive facial blushing rather than as a primary social-anxiety condition.
The secondary-anxiety interpretation draws support from the relative absence of typical childhood inhibition and personality features, as well as from patients’ belief that eliminating blushing would eliminate their social fear. The authors compare this structure with social anxiety associated with essential tremor, motor disability, or stuttering. Blushing remains an ambiguous case, however. It may arise from emotion and anxiety without a clearly prior physical disturbance, yet vascular or other physiological causes can contribute in some people. Patients may also subjectively magnify the intensity of their blushing and become completely intolerant of it, a pattern that resembles other body-focused concerns near the social-anxiety spectrum.
The design imposes important limits. Participants came from specialized clinical centers and cannot represent the general population. The data establish neither the prevalence of fear of blushing in the public nor its prevalence among all people with social anxiety disorder. About 90 percent of the blushing-only group had been referred by the surgery department. The central group differences remained when referral origin was considered, which argues against a wholly artifactual result, but the sample still chiefly characterizes people seeking sympathectomy and undergoing psychological assessment. It cannot establish the profile of individuals who never approach either surgical or psychiatric services.
The study is also cross-sectional, so it compares profiles at one point rather than following their development. Age differences among the groups may account for some variation in comorbidity or personality, while retrospective reports of onset are vulnerable to recall error. The data could not reliably establish whether excessive blushing began before, after, or alongside social anxiety. The conclusion is therefore a proposal for classification and further research, not a basis for individual diagnosis. A blushing-only presentation appears clinically distinctive, but its validity, epidemiology, course, and treatment response still require study. The clearest practical implication is one of detection: a complaint framed as a physical problem may conceal severe social suffering that could remain unseen without communication among surgery, primary care, and mental-health services.
Synthesis generated by GPT-5.6 from the normalized text of the work. It is a reading aid, not a substitute for reading or citing the text.
- Availability
- Text available
- Text quality
- Automatic checks passed
- Text format
- Text recognized from the scan
- Document type
- Document
- Usage rights
- Authorized for this project
- Excerpts
- 29
- Translation
- GPT-5.6 · non-official AI, reviewed
Is There a Place for Fear of Blushing in Social Anxiety Spectrum? page 1
PDF page 1, excerpt 1/3
Non-official AI translation
DÉPRESSION ET ANXIÉTÉ 29 : 62-70 (2012)
Article de recherche
LA PEUR DE ROUGIR A-T-ELLE UNE PLACE DANS LE SPECTRE
DE L’ANXIÉTÉ SOCIALE ?
Antoine Pelissolo, M.D. Ph.D.,'* Albert Moukheiber, Ph.D.,! Corine Lobjoie, M.A.,' Jean Valla, M.D.,’
et Simon Lambrey, M.D. Ph.D.!
PDF page 1, excerpt 2/3
Non-official AI translation
Contexte : La peur de rougir (PR) devant d’autres personnes est un problème fréquent et
potentiellement invalidant, mais elle n’est pas encore décrite comme un diagnostic spécifique
dans les classifications psychiatriques. Cela peut s’expliquer par le manque d’études
comparatives avec d’autres formes de trouble d’anxiété sociale (TAS). Notre objectif était donc
d’explorer la spécificité de la PR chez des patients atteints de TAS. Méthodes : Des patients atteints de TAS avec
PR mais sans autre menace sociale (n = 142), dont la majorité avait été
adressée par un service de chirurgie après une demande initiale de blocage sympathique
pour le rougissement facial, ont été comparés à des patients atteints de TAS avec PR et autres
peurs sociales associées (n = 97), ainsi qu’à des patients atteints de TAS sans PR (n = 190). Ils ont été
évalués et comparés au moyen d’un entretien diagnostique structuré pour le DSM-IV et
de diverses échelles mesurant l’anxiété sociale, d’autres symptômes anxieux et dépressifs,
le retentissement fonctionnel et les traits de personnalité. Résultats : Le groupe présentant une PR pure montrait
des profils spécifiques par rapport aux deux autres groupes : âge de début plus tardif, moindre
comorbidité, inhibition comportementale et tempéramentale plus faible, et meilleure estime
de soi. Toutefois, leurs niveaux d’anxiété sociale et de retentissement fonctionnel étaient élevés.
Aucune différence importante n’est apparue entre les deux autres groupes. Conclusion :
La spécificité de la PR devrait être prise en compte dans le spectre de l’anxiété sociale et
pourrait être considérée soit comme un sous-type de TAS, soit comme une forme de TAS secondaire au
rougissement facial. D’autres études épidémiologiques et thérapeutiques sur ce trouble sont
nécessaires. Depression and Anxiety 29:62-70, 2012. © 2011 Wiley-Liss, Inc.
Mots-clés : trouble d’anxiété sociale ; rougissement social ; phobie sociale ; sous-types ;
classification ; érythrophobie
PDF page 1, excerpt 3/3
Non-official AI translation
INTRODUCTION Certaines formes spécifiques de TAS ont fait l’objet
d’études comparatives, telles que les peurs spécifiques de parler
La peur de rougir (PR) est un trouble fréquent qui n’est pas devant un public, d’aborder l’intimité,
encore spécifiquement répertorié dans les classifications psychiatriques. Le rougissement est l’un des symptômes du trouble d’anxiété sociale
(TAS),""] et certains patients présentant cette affection ‘Département de psychiatrie adulte, Hôpital Pitié-Salpêtrière,
développent une phobie du rougissement.?->] Cependant, certains « rougisseurs AP-HP, UPMC, CNRS USR3246 Paris, France
sociaux » se plaignent avant tout d’une PR pathologique qui 2Département de chirurgie, Clinique de Bercy, Charenton-le-
semble être au cœur de leur pathologie.!! Très peu d’études cliniques Pont, France
ont examiné les caractéristiques de ce syndrome *Correspondance à adresser à : Antoine Pelissolo, Service de psychiatrie
et ses liens avec le TAS. adulte, Hôpital Pitié-Salpêtrière, 47, bd de l’hôpital 75651 Paris
Dans le DSM-IV, la catégorie diagnostique du TAS ne comporte Cedex 13, France. E-mail : antoine.pelissolo @ upmc.fr
qu’un seul sous-type : la forme généralisée, qui s’applique à
tous les patients présentant des signes d’anxiété dans plusieurs
situations sociales." Tous les autres patients doivent être considérés comme
Les auteurs déclarent n’avoir aucune relation financière à divulguer au cours des
3 dernières années.
« non généralisés ». Toutefois, le TAS est connu pour être un Reçu pour publication le 24 novembre 2010 ; révisé le 10 mai
trouble hétérogène : des sous-groupes de patients peuvent présenter 2011 ; accepté le 18 mai 2011
des caractéristiques différentes susceptibles d’affecter la présenta- DOI 10.1002/da.20851
tion clinique, l’évolution et la réponse au traitement.!4 Publié en ligne dans la Wiley Online Library (wileyonlinelibrary.com).
© 2011 Wiley-Liss, Inc.